Oral contraceptives and venous thromboembolism: Should epidemiologic associations drive clinical decision making?
Open Access
- 31 July 1996
- journal article
- editorial
- Published by Elsevier in Contraception
- Vol. 54 (1) , 1-3
- https://doi.org/10.1016/0010-7824(96)00111-4
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The increased risk of venous thromboembolism and the use of third generation progestagens: Role of bias in observational researchContraception, 1996
- Oral contraceptives and thrombotic diseases: Impact of new epidemiological studiesContraception, 1996
- Third generation oral contraceptives and risk of myocardial infarction: an international case-control studyBMJ, 1996
- Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control studyBMJ, 1996
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagenThe Lancet, 1995
- Third generation oral contraceptive pillsBMJ, 1995
- Advising women on which pill to takeBMJ, 1995
- The risk of venous thromboembolism associated with low oestrogen oral contraceptivesJournal of Obstetrics and Gynaecology, 1995
- Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic DiseaseAmerican Journal of Epidemiology, 1991